model studies shown potential clinical advantages charged particles protons light ions compared radiotherapy radiotherapy imrt disease sites newly developed proton therapy impt yields superior dose distributions photon imrt added advantage significant reduction volume healthy normal tissues exposed doses initially major emphasis clinical research proton light ion therapy dose escalation inherently radioresistant tumors lesions adjacent critical normal structures constrained dose safely delivered conventional therapy advent imrt particle therapy gradually shifted protocols aimed morbidity reduction lately emphasis placed potential reduced risk carcinogenesis protons compared increase theoretically estimated use imrt larger integral volumes pediatric setting higher inherent susceptibility tissues risk significant benefits protons strongly emphasized literature significant expansion particle therapy facilities world increasing public awareness potential benefits particle therapy wider accessibility patients require treating physicians stay abreast clinical indications radiotherapy modality article reviews available literature various disease sites particle therapy traditionally considered offer clinical advantages highlight current lines clinical research issue second malignancies examined light controversial epidemiological evidence available particle therapy discussed c NUMBER american cancer society references NUMBER 3d conformal 3d crt intensity modulated intensity modulated low medium x ray radiation induced 3d crt NUMBER fold radiation induced cost effectiveness